Dailymed calcium acetate hyperphosphatemia chronic kidney disease?

It sounds like you’re asking about calcium acetate (a phosphate binder) in the setting of hyperphosphatemia due to chronic kidney disease (CKD), likely referencing DailyMed labeling. Here’s the key information you’d typically find/need:

What it’s for

Calcium acetate is used to control hyperphosphatemia in:

• CKD patients on dialysis, and/or
• CKD patients not on dialysis (depending on the specific product/labeling)

It works by binding dietary phosphate in the gut, reducing phosphate absorption.

Common “DailyMed-style” label points to look for

Dose / how it’s taken

• Usually taken with meals (and sometimes with snacks).
• The goal is to reduce serum phosphorus by binding the phosphate you eat.

Important: dosing is often phosphorus-target driven and adjusted based on lab results.

Monitoring

You typically need ongoing monitoring for:

• Serum phosphate
• Serum calcium
• Calcium–phosphate (Ca×P) product
• Parathyroid hormone (PTH) trends in CKD-MBD management

Warnings / risks

Main concerns with calcium-based binders:

• Hypercalcemia (calcium levels too high)
• Constipation / GI effects
• Vascular/soft tissue calcification risk can be higher when calcium/phosphate balance is unfavorable (reflected in labeling as concern about Ca×P product)

Practical considerations in CKD hyperphosphatemia

• Calcium acetate is often chosen when calcium levels and Ca×P product are acceptable.
• If a patient tends toward high calcium or high Ca×P product, clinicians may consider non-calcium binders instead (e.g., sevelamer, lanthanum, iron-based binders)—depending on the patient and formulary.

If you want, I can be precise

To match the exact DailyMed entry you mean, tell me one of these:

1. The brand/product name (e.g., “PhosLo” or generic), or
2. The DailyMed “Drug Label” link, or
3. Your question: dose, warnings, interactions, or contraindications.

Also—are you asking for adult or pediatric use, and dialysis or non-dialysis CKD?